Other News

News News in Brief

News in brief: Cancer AI diagnostic tool developed, rapid testing tech to be scaled, ICS place-based partnerships

Another week, another round of innovative and exciting health tech developments. Over the past seven days or so, we’ve seen Prostate Cancer Research announce partnerships with health tech start-ups, the launch of NICE’s new five-year strategy, and Alcidion’s acquisition of a patient flow software company. We also reported this week […]

News

HTN health tech tour continues…dates announced for June

HTN Now April may have come to a close but, here at HTN, preparations are already underway for our next live series in June! Taking place 14-17th June, our health tech tour continues, and once again, offers speakers from across the industry the opportunity to discuss their programmes, learnings, approach […]

News

New NHS hospital prescriptions data available for COVID-19 researchers

NHSX and NHS Digital have announced that a new data resource for secondary care prescriptions is now available to COVID-19 researchers. The data collection focuses on medicines that are prescribed and administered in hospitals – providing daily information harvested from electronic prescription and administration systems at secondary care NHS trusts […]

Apps

Prostate Cancer Research partners with health-tech start-ups

Prostate Cancer Research has announced it’s partnering with Vine Health, a free information health app, and Lucida Medical, a company specialising in early detection of cancer. The Vinehealth app will be updated with new information from Prostate Cancer Research to support people with a reliable source of information. The partnership aims to work […]

News

NICE launches five-year strategy with focus on data, technologies and innovations

NICE has today published a five-year strategy with an increased focus on new treatments, technologies and innovations. In the strategy the body highlights its four priority areas of focus; ‘rapid, robust, and responsive technology evaluation’, ‘dynamic, living guideline recommendations’, ‘effective guidance uptake to maximise impact’ and ‘leadership in data, research […]